Dr. Leopold is a Post-Doctoral Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She received an Erwin Schroedinger Stipend from the Austrian Science Fund as well as a Thomas O. Pyle Research Scholarship from Harvard Medical School. Currently she works on various studies in which she assess the impact of policy changes (regulatory or coverage) on the utilization of metastatic breast cancer treatments by looking at trends in claims data. In addition, Dr. Leopold performed a qualitative study on the adaptability of pharmacy benefits systems to the current challenges of high-cost specialty medicines in various high-income countries. Her main research interests include ethical considerations in pharmaceutical pricing and reimbursement, evidence-based decision-making in pharmaceutical policy as well as the evaluation of the pharmaceutical policies’ impact on affordability and availability of medicines. Prior to joining the Department of Population Medicine at Harvard Medical School she co-led the Austrian Centre for Rare Disease as well as the European Network of public authorities of Pharmaceutical Pricing and Reimbursement Information (PPRI) at the Department of Health Economics at the Austrian Health Institute / WHO Collaborating Center for Pharmaceutical Pricing and Reimbursement Policies. She holds a doctorate in Pharmaceutical Policy from Utrecht University, Utrecht Institute for Pharmaceutical Science / WHO Collaborating Centre for Pharmaceutical Policy and Regulation in the Netherlands and a Master of Science degree from Bocconi University in Italy.